severe pre-eclampsia
severe pre-eclampsia
Explore linked clinical trials. Standard reference: MONDO:00016416 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Role of Postpartum Furosemide in Recovery of Patients With Severe Preeclampsia | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, cardiovascular disorder, hypertension, pregnancy-induced, hypertensive disorder, preeclampsia, pregnancy disorder, severe pre-eclampsia, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT07861685 | |
| Identification of Genes of Interest for Severe Forms of Preeclampsia | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder, severe pre-eclampsia | Not yet recruiting | Not stated | 2026-07-14 | NCT07703826 | |
| Algorithm-Based Timing of Delivery Using the sFlt-1/PlGF Ratio in Early-Onset Severe Preeclampsia. (MAP 2 Study : Management Based on Angiogenic Markers in Preeclampsia 2 Study ) | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder, severe pre-eclampsia | Not yet recruiting | Not applicable | 2026-06-24 | NCT07665112 | |
| Furosemide vs Placebo in Severe Preeclampsia Postpartum | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, cardiovascular disorder, hypertension, pregnancy-induced, hypertensive disorder, preeclampsia, pregnancy disorder, severe pre-eclampsia, vascular disorder | Not yet recruiting | Phase 2 | 2026-06-15 | NCT07648251 | |
| Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder, severe pre-eclampsia | Not yet recruiting | Not stated | 2026-04-23 | NCT07547046 | |
| Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure | Female Urogenital Diseases and Pregnancy Complications, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, eclampsia, hypertension, pregnancy-induced, nervous system disorder, preeclampsia, pregnancy disorder, severe pre-eclampsia, visual epilepsy | Not yet recruiting | Phase 3 | 2025-10-24 | NCT07220902 |